General Practice · Mayaguez, PR
NPI
1528376118
Since 2010
Specialty
General Practice
Code 208D00000X
Group practices
0
Medicare group memberships
Hospitals
1
Hospital affiliations
14 N Peral St, Edificio la Palma 2-B
Mayaguez, PR, 00680
Phone (787) 834-3535
Medicare paid, 2024
$6,442
119 services
Medicare patients, 2024
30
Average age 76
Drug cost, 2024
$1.9M
34,616 prescriptions
Company payments, 2025
$315
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Antonio R Olivencia-Echeandia was code 99213 (office e&m - established), 45 times for 22 patients. In total Antonio R Olivencia-Echeandia billed 119 services in 11 codes, and Medicare paid $6,442.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-09-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 45 | 22 | $52.78 | $2,375 |
| 99212 Office E&M - Established | Office | 24 | 15 | $36.58 | $878 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 19 | 19 | $127.90 | $2,430 |
| 99211 Office E&M - Established | Office | 16 | 11 | $12.47 | $199 |
By year: 2022 $8,113 for 170 services; 2023 $6,920 for 143 services; 2024 $6,442 for 119 services.
Medicare prescription drug claims, 2024
In 2024, the drug Antonio R Olivencia-Echeandia prescribed most often to Medicare patients was Gabapentin, with 1,678 prescriptions and refills. In total Antonio R Olivencia-Echeandia wrote 34,616 Medicare prescriptions that cost $1.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 1,678 | 1,897 | 223 | $14K |
| Levothyroxine Sodium Generic | 1,414 | 1,698 | 176 | $12K |
| Omeprazole Generic | 1,084 | 1,220 | 146 | $7,282 |
| Amlodipine Besylate Generic | 1,017 | 1,287 | 140 | $4,139 |
| Pantoprazole Sodium Generic | 900 | 1,026 | 133 | $7,039 |
| Atorvastatin Calcium Generic | 894 | 1,999 | 212 | $9,242 |
| Metoprolol Succinate Generic | 864 | 1,091 | 130 | $8,869 |
| Montelukast Sodium Generic | 792 | 902 | 113 | $6,635 |
| Tamsulosin Hcl Generic | 737 | 844 | 105 | $5,426 |
| Losartan Potassium Generic | 724 | 1,766 | 177 | $9,078 |
| Rosuvastatin Calcium Generic | 673 | 1,451 | 152 | $8,692 |
| Ezetimibe Generic | 654 | 861 | 97 | $7,705 |
| Simvastatin Generic | 643 | 1,544 | 151 | $5,474 |
| Alendronate Sodium Generic | 599 | 686 | 84 | $3,557 |
| Famotidine Generic | 556 | 628 | 88 | $3,719 |
Brand drugs: 4,104 claims; generic drugs: 30,408 claims; opioid claims: 165.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Antonio R Olivencia-Echeandia $315 ($315 in general payments such as food, travel and fees) from 6 companies. The largest payer was Dexcom, Inc. with $80.74.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.